Home > Publications . Search All . Browse All . Country . Browse PSC Pubs . PSC Report Series

PSC In The News

RSS Feed icon

Eisenberg says many colleges now train campus personnel to spot and refer troubled college students

Farley on new strategies for city insolvencies in Michigan

Owen-Smith says universities must demonstrate value of higher education

Highlights

Call for papers: Conference on Integrating Genetics and the Social Sciences, Oct 21-22, 2016, CU-Boulder

PRB training program in policy communication for pre-docs. Application deadline, 2.28.2016

Call for proposals: PSID small grants for research on life course impacts on later life wellbeing

PSC News, fall 2015 now available

Next Brown Bag

Monday, Feb 1 at noon, 6050 ISR-Thompson
Sarah Miller

Comparison of the Racial/Ethnic Prevalence of Regular Aspirin Use for the Primary Prevention of Coronary Heart Disease from the Multi-Ethnic Study of Atherosclerosis

Archived Abstract of Former PSC Researcher

Sanchez, D.R., Ana Diez Roux, E.D. Michos, R.S. Blumenthal, P.J. Schreiner, G.L. Burke, and K. Watson. 2011. "Comparison of the Racial/Ethnic Prevalence of Regular Aspirin Use for the Primary Prevention of Coronary Heart Disease from the Multi-Ethnic Study of Atherosclerosis." American Journal of Cardiology, 107(1): 41-46.

In 2002, the United States Preventive Services Task Force and the American Heart Association recommended aspirin for the primary prevention of coronary heart disease in patients with Framingham risk scores >= 6% and >= 10%, respectively. The regular use of aspirin (>= 3 days/week) was examined in a cohort of 6,452 White, Black, Hispanic, and Chinese patients without cardiovascular disease in 2000 to 2002 and 5,181 patients from the same cohort in 2005 to 2007. Framingham risk scores were stratified into low (< 6%), increased (6% to 9.9%), and high (>= 10%) risk. In 2000 to 2002 prevalences of aspirin use were 18% and 27% for those at increased and high risk, respectively. Whites (25%) used aspirin more than Blacks (14%), Hispanics (12%), or Chinese (14%) in the increased-risk group (p < 0.001). Corresponding prevalences for the high-risk group were 38%, 25%, 17%, and 21%, respectively (p < 0.001). In 2005 to 2007 prevalences of aspirin use were 31% and 44% for those at increased and high risk, respectively. Whites (41%) used aspirin more than Blacks (27%), Hispanics (24%), or Chinese (15%) in the increased-risk group (p < 0.001). Corresponding prevalences for the high-risk group were 53%, 43%, 38%, and 28%, respectively (p < 0.001). Racial/ethnic differences persisted after adjustment for age, gender, diabetes, income, and education. In conclusion, regular aspirin use in adults at increased and high risk for coronary heart disease remains suboptimal. Important racial/ethnic disparities exist for unclear reasons. (c) 2011 Elsevier Inc. All rights reserved. (Am J Cardiol 2011;107:41-46)

DOI:10.1016/j.amjcard.2010.08.041 (Full Text)

PMCID: PMC3021117. (Pub Med Central)

Country of focus: United States of America.

Browse | Search : All Pubs | Next